Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05901519 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Pilot Study of Liver Protection Using Prednisone for Patients Receiving Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma

StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 6 months later Aug 2026 → Mar 2027
See other at-risk trials from University of Michigan Rogel Cancer Center

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary and study completion pushed from Aug 2026 to Mar 2027
    • Eligibility criteria expanded, about 20 words
    • Secondary endpoints: details revised at 2 of 5 entries
  2. 2 versions Re-verified since Mar 11, 2025, no change to tracked fieldsv6-v7
  3. Start date changed from estimate of Feb 2024 to Feb 16, 2024v5
  4. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    • Primary and study completion dates: Jul 2026 to Aug 2026
    • Start date: Jan 2024 to Feb 2024
    v4
  5. Start date: Sep 2023 to Jan 2024
    • Primary and study completion dates: Mar 2026 to Jul 2026
    v3
  6. Start date: Jun 2023 to Sep 2023
    • Primary and study completion dates: Dec 2025 to Mar 2026
    v2
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Patients on this study will self administer Prednisone for three days before starting Radiation Therapy (RT) and continue to take 60 mg/day during the first three fractions of RT.
Trial Details
NCT Number NCT05901519
Lead Sponsor University of Michigan Rogel Cancer Center
Conditions
(from sponsor)		 Hepatocellular Carcinoma
Related terms Carcinoma, Hepatocellular
Enrollment 20 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov